Invenra
PrivateLast Round
Debt
Apr 10, 2020
Total Funding Raised
$18.89M
Momentum Score
25 /100
Company Overview
Invenra is a private biotechnology company that specializes in the discovery and development of next-generation biologics, with a particular focus on multi-specific antibodies for therapeutic applications. The company's proprietary platforms, including the B-Body® Bispecific Platform, enable the high-throughput screening and creation of novel antibody candidates. With an initial focus on oncology, Invenra collaborates with pharmaceutical and biotechnology partners to advance pipelines of bi- and multi-specific antibodies. The company was founded in 2011 and is headquartered in Madison, Wisconsin.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invenra Comps
Public and private peers based on sector, stage, and business model.
Invenra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Apr 10, 2020 | ||||
| Series B | Oct 17, 2018 | ||||
| Series A Extension | Oct 3, 2017 | ||||
| Series A Extension | Jul 18, 2016 | ||||
| Series A Extension | Aug 24, 2015 | ||||
Series A | Feb 19, 2013 |
Invenra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| State of Wisconsin Investment Board | Series B |
| Venture Investors LLC | Series B |
| State of Wisconsin Investment Board (SWIB) | Series B |
| Venture Management, LLC | Series A Extension |
| Wisconsin Investment Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Partnering with Xcellon Biologics to develop new antibody therapeutics.
- Jul 14, 2025
Dr. Alan J. Korman joins the Scientific Advisory Board.
Invenra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Invenra's valuation, stock price, and market status.
